BWAY Stock Analysis: Buy, Sell, or Hold?
BWAY - Brainsway Ltd. American Depositary Shares
$14.38
-0.51 (-3.43%)
▼
5d:
-1.71%
30d:
-5.89%
90d:
+5.27%
BUY
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When BWAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BWAY shows positive signals but monitor for confirmation. Market pricing in 16.8% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BWAY shows positive signals but monitor for confirmation. Market pricing in 16.8% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$22.72
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$14.11
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BWAY is currently trading at $14.38, which is considered slightly low relative to its 30-day fair value range of $14.22 to $15.39. From a valuation perspective, the stock is trading at a discount (Forward PE: 30.8) compared to its historical average (53.4). Remarkably, the market is currently pricing in an annual earnings decline of 16.8% over the next few years. This pessimistic expectation contrasts with the company's recent 200% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BWAY is in a strong downtrend. Immediate support is located at $13.93, while resistance sits at $15.05. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.67 (+15.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BWAY is in a strong downtrend. Immediate support is located at $13.93, while resistance sits at $15.05. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.67 (+15.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$14.22 -
$15.39
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading below Wall St target ($16.67)
Trading Range Analysis
30-Day Trading Range
$14.22 -
$15.39
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$13.93
Resistance Level
$15.05
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.81
Wall Street Target
$16.67
(+15.9%)
Revenue Growth (YoY)
34.6%
Earnings Growth (YoY)
200.0%
Profit Margin
15.6%
Valuation Discount vs History
-16.8% cheaper
PE vs Historical
30.8 vs 53.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.8%
(market-implied from PE analysis)
1-Year Target
$12.94
(-10%)
2-Year Target
$11.65
(-19%)
3-Year Target
$10.48
(-27%)
3-Yr Target (if PE normalizes)
(PE: 31→53)
$18.17
(+26%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.8, Growth: 53.9%)
$48.53
(+238%)
Base:
(SPY PE: 21.8, Growth: 53.9%)
$34.31
(+139%)
Bear:
(PE: 18.5, Growth: 53.9%)
$29.16
(+103%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (31x PE) as earnings recover.
Forward PE: 35.46 | Forward EPS (Implied): $0.41
Bull Case
$17.36
(+21%)
Analyst growth 15.0%, PE expands to 37.2
Base Case
$14.38
(0%)
Market implied 0.0%, PE stable at 35.5
Bear Case
$11.00
(-24%)
Severe decline -15.0%, PE contracts to 31.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 30.8 to 53.4
Stabilization Target:
$24.92
(+73.3%)
PE Expansion Potential:
+73.3%
Share & Embed Analysis
Last updated: June 23, 2026 7:48 AM ET
Data refreshes hourly during market hours. Next update: 8:48 AM
Data refreshes hourly during market hours. Next update: 8:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BWAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 52 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 60 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 63 BUY |
